Hui Jin
Directeur/Membre du Conseil chez Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Profil
Hui Jin currently works at Zhejiang Hongyuan Pharmaceutical Co., Ltd., as Director & Manager.
Postes actifs de Hui Jin
Sociétés | Poste | Début |
---|---|---|
Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Zhejiang Hongyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Hongyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredient (API) of cardio-cerebral vascular drugs, intermediates, and other chemicals. Its products include intermediates of Atorvastatin Calcium, Rosuvastatin Calcium, Pregabalin, Empagliflozin, Sotagliflozin, Teneligliptin, Betrixaban, Edoxaban, Sacubitril, Baricitinib, Lifitegrast, Roxadustat, Palbociclib, Ribociclib, Abemaciclib, Rucaparib, and Duloxetine. The company was founded on June 16, 2005 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Zhejiang Hongyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Hongyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredient (API) of cardio-cerebral vascular drugs, intermediates, and other chemicals. Its products include intermediates of Atorvastatin Calcium, Rosuvastatin Calcium, Pregabalin, Empagliflozin, Sotagliflozin, Teneligliptin, Betrixaban, Edoxaban, Sacubitril, Baricitinib, Lifitegrast, Roxadustat, Palbociclib, Ribociclib, Abemaciclib, Rucaparib, and Duloxetine. The company was founded on June 16, 2005 and is headquartered in Hangzhou, China. | Health Technology |